Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Jul. 31, 2025	Jul. 31, 2024
Operating Activities
Net income (loss)	$ (43.9)	$ 185.0
Adjustments to reconcile net income (loss) to net cash provided by (used for) operations:
Depreciation	85.0	73.0
Amortization	50.2	56.0
Share-based compensation expense	9.0	8.9
Deferred income tax expense (benefit)	24.0	2.6
Other noncash adjustments – net	12.7	15.1
Changes in assets and liabilities:
Trade receivables	(24.3)	1.6
Inventories	(177.3)	(99.0)
Other current assets	53.0	2.6
Accounts payable	(33.2)	(61.5)
Accrued liabilities	76.2	(60.9)
Income and other taxes	(41.1)	54.9
Other – net	(0.9)	(5.4)
Net Cash Provided by (Used for) Operating Activities	(10.6)	172.9
Investing Activities
Additions to property, plant, and equipment	(84.3)	(123.7)
Proceeds from disposal of property, plant, and equipment	12.9	0.0
Collateral pledged for derivative cash margin accounts	(126.7)	(48.6)
Other – net	0.2	(0.1)
Net Cash Provided by (Used for) Investing Activities	(197.9)	(172.4)
Financing Activities
Short-term borrowings (repayments) – net	300.6	96.2
Quarterly dividends paid	(114.4)	(112.1)
Purchase of treasury shares	(4.6)	(2.6)
Other – net	(3.6)	(4.5)
Net Cash Provided by (Used for) Financing Activities	178.0	(23.0)
Effect of exchange rate changes on cash	(0.1)	0.0
Net increase (decrease) in cash and cash equivalents	(30.6)	(22.5)
Cash and cash equivalents at beginning of period	69.9	62.0
Cash and cash equivalents at end of period	$ 39.3	$ 39.5